After a few months away, I’m back to doing shorts. A lot happened irl that messed up my scheduling; honestly, it’s still ongoing. This is an attempt on my part to get back on track. Wish me luck…
Tragedy in the Realm of God
Author: Kazekozo
Title: The Price of Immortality
Prologue
Humanity has long pursued the dream of immortality. Ancient alchemists sought elixirs of immortality, while modern scientists harnessed the power of genetic manipulation and AI technology to achieve this dream. At last, scientists believed they had found the answer. However, the answer brought about a tragedy beyond imagination.
Chapter 1: A Beacon of Hope
Takashi Sato’s company, Eternal Life, was a biotechnology company that was highly regarded by scientists and doctors around the world. The company was known for developing innovative medical technologies and treatments, the most notable of which was “Project Eternal”, a technology for immortality.
Takashi had a keen interest in science from an early age, and was particularly fascinated by genetics. His parents were both doctors, and partly due to their influence, he decided to pursue a career in medicine. But his goal wasn’t just to cure people, he was to unravel the underlying mysteries of life and find the ultimate cure. He majored in genetic engineering in college and after earning his Ph.D., he got a job at Eternal Life.
“Project Eternal” was a combination of genetic manipulation and artificial intelligence to completely halt the aging process in human cells. Takashi was deeply involved in the research as one of the central figures of the project. His team was developing new methods to control gene repair and regeneration, with the goal of not only delaying aging, but stopping it altogether.
Takashi devoted himself to the research day and night, repeating numerous trials and errors. As a result of his efforts, he finally achieved success in the early experimental stages. In animal studies, the test mice healed their wounds at an astonishing rate and showed no signs of aging. This achievement was very encouraging for Takashi and his team.
However, human applications were still a long way off. There were many ethical issues and safety concerns, and further research and validation were needed. Nevertheless, Eternal Life’s upper management was keenly interested in the potential of this technology and was pressuring them to put it into practical use as soon as possible.
One day, Takashi was in the laboratory analyzing experimental data with his colleague Yuki Nakamura. Yuki was an expert in cell biology and, like Takashi, was passionate about “Project Eternal”. The two spent long hours observing changes in mouse cell samples.
“Look, Takashi. This is the latest sample data.” Yuki said as she pointed to the monitor. “The rate of cell division is more stable, and the signs of aging have completely disappeared.”
“That’s amazing, Yuki,” Takashi exclaimed. “If we can apply this to humans, we may be able to truly achieve immortality.”
“But we can’t let our guard down just yet. Human cells are more complex, and unforeseen problems may arise.”
“Yes. There are also ethical issues to consider, and safety must be our top priority.” Takashi replied with a serious expression.
After that, Takashi and Yuki continued their research and collected various data. Finally, Eternal Life’s upper management made the decision to begin clinical trials with human subjects. They assembled a carefully selected group of volunteers to test this innovative technology.
At the start of the trial, Takashi and his colleagues interviewed each subject and asked for detailed explanations and consent. The subjects all had high hopes for the technology and were betting on the possibility of immortality.
As the trial began, changes began to appear in the subjects’ bodies. At first, the changes were subtle, but gradually the effect became apparent. The subjects had younger-looking skin, increased physical strength, and improved resistance to disease. The media reported the results of the trial extensively, and people worldwide were filled with excitement and anticipation.
Eternal Life then moved forward with preparations to commercialize the technology. Many companies and investors took notice of the project, and huge sums of money flowed in. Takashi and other researchers believed that the technology would benefit people around the world.
However, there was a serious problem lurking behind the scenes. Some of the subjects began experiencing unexpected side effects. They complained of severe headaches, vision loss, muscle spasms, and other symptoms, and their physical condition gradually deteriorated. Takashi was very anxious about this situation and tried hard to find the cause.
Takashi’s laboratory was in turmoil for a while. Researchers worked day and night to determine the cause, analyzing vast amounts of data. However, the root cause of the problem was not easily identified. Due to the complex interplay between genetic manipulation and AI technology, data analysis took time.
One night, Takashi was left alone in the laboratory to continue analyzing the data. Impatience and anxiety swirled in his heart. He wondered if the technology was really safe.
“What the hell am I doing wrong?” muttered Takashi as he stared at the data on the monitor.
At that moment, Yuki walked into the laboratory. “Takashi, are you still here? You should get some rest.”
“Yuki,” Takashi looked back with a tired expression, “Something isn’t right. The subjects’ symptoms are getting worse and worse. But I don’t know why.”
“There must be something we’ve missed. Let’s go through the data again. We might find some clues.”
The two began analyzing the data again. After a few hours, Yuki suddenly spoke up. “Takashi, look at this!”
The data that Yuki pointed to showed abnormal cell proliferation patterns. Takashi checked the data in detail and was astonished.
“Maybe this is the reason…” said Takashi, his voice trembling, “As a result of the genetic manipulation of the cells to stop aging, the cells began to proliferate abnormally. This was putting a strain on the subjects’ bodies.”
Yuki was also staring at the data with a stunned expression. “Such a … if this continues, the lives of the subjects will be in danger.”
Takashi made up his mind and decided to report to his superiors immediately. However, the reaction of the upper management was unexpected. They decided to cover up this fact and continue with the project. With huge profits at stake, they had no regard for the risks involved.
Takashi was furious and disappointed. He felt a strong sense of ethical responsibility. He could not ignore the reality that his research was harming people. Takashi refused to obey the decisions of his superiors and decided to act on his own convictions.
Chapter 2: The Beginning of the Crisis
Takashi secretly held a meeting with Yuki and other trusted colleagues and began to formulate a plan to oppose the decision of the upper management. They made copies of the data, stored them in a secure location, and continued to monitor the health of the subjects.
“We must reveal the truth,” Takashi emphasized at the meeting. “Now that we know that this technology poses a danger to people, we can’t remain silent.”
Yuki agreed. “Takashi is right. We have a responsibility as scientists and as human beings. We must do everything in our power to protect the subjects.”
They gathered evidence and prepared to go public. However, the upper management also sensed the movement and tightened surveillance. Takashi and the others had to act covertly.
One night, Takashi returned home and sank his tired body into the couch. His wife, Akira, snuggled up to him, looking anxious. “Takashi, you seem to be tired all the time lately. Is something wrong?”
“Akira, I’m sorry, I’m having a little trouble at work…” Takashi replied vaguely, but he didn’t go into details because he didn’t want to worry his wife.
“But don’t push yourself too hard. Your health is the most important thing.” Akira gently squeezed his hand.
“Thank you, Akira. Your words are encouraging.” Takashi smiled and shook his wife’s hand.
The next day, Takashi returned to the laboratory and worked again on analyzing data and gathering evidence. With the help of Yuki and his other colleagues, he gradually gathered evidence. However, the pressure from the upper management only increased, and it was only a matter of time before their actions were discovered.
One day, Takashi and his friends learned that an important meeting will be held. The meeting was scheduled to discuss the progress of “Project Eternal” and its future direction. Takashi planned to use this opportunity to appeal directly to the upper management.
On the day of the meeting, Takashi and Yuki headed to the conference room with nervous looks on their faces. The executives of “Eternal Life” were gathered there, and the atmosphere was solemn. Takashi took a deep breath and made up his mind.
As the meeting began, Takashi raised his hand and asked for a statement. “As one of the people in charge of this project, I have an important report to make.”
The executives looked surprised, but gave Takashi a chance to speak. Takashi took a step forward and projected the data he had prepared on the screen.
“Please take a look at this data. It shows the latest health status of our subjects.” Takashi calmly began to explain. “Although we have succeeded in halting aging through genetic manipulation, the cost is abnormal cell proliferation. If this continues, the lives of our subjects may be in danger.”
The conference room fell silent for a moment. The executives stared at the data on the screen, and their expressions became increasingly grim.
“Takashi, is this true?” one of the executives exclaimed. “I never imagined that this technology would pose a danger to people.”
“I’ve checked all the data. Unfortunately, this is the case.” Takashi replied emphatically. “We should stop the project immediately and focus on treating the subjects.”
However, the other executives remained callous. “Takashi, I understand your concerns, but a huge amount of money and time has been invested in this project. We can’t stop it now.”
“But people’s lives will be in danger if we don’t!” exclaimed Takashi. “We must not forget our ethics and responsibilities as scientists.”
The executives looked at each other and quietly began discussions. After a while, one of the executives said in a calm voice. “Takashi, while we respect your opinion, as a company, we have decided to proceed with the project. We will ask you to continue working on your research.”
Takashi was appalled by his words. Although he was deeply disappointed by the indifferent attitude of his executives, he still could not give up. After the meeting, Takashi returned to the laboratory with Yuki to think about what to do next.
“Takashi, it’s really dangerous if things continue like this.” Yuki said worriedly. “We’ve got to do something.”
“I agree. Let’s take another look at the data. Maybe we’ll find a breakthrough.” Takashi renewed his resolve and decided to continue his research.
Chapter 3: Signs of Dark Clouds
Takashi and Yuki worked again to analyze the data and try to find the cause of the abnormal cell growth. They suspected that there might be a problem with the genetic manipulation process or the AI algorithm, so they conducted a detailed analysis.
After several weeks, they finally made an important discovery. The genetic manipulation of the cells had successfully halted cell aging, but at the same time, an abnormality had occurred in the cell’s repair mechanism. This caused the cells to proliferate uncontrollably, increasing the risk of tumors forming in the body.
“Is this the cause?” muttered Takashi as he stared at the data on the monitor, “I never thought the side effects of genetic manipulation would manifest themselves in this way…”
“It’s really dangerous as it is,” Yuki said with a serious expression. “We have to improve this technology immediately.”
“But I don’t know if the upper management will allow it…,” Takashi said anxiously, “They are putting profit first.”
“Even so, we won’t give up,” Yuki said with great determination. “We must do everything we can to protect the subjects.”
Takashi and Yuki decided to explore a new approach and review the genetic manipulation process. They continued to improve the AI’s algorithms and searched for ways to make the cell’s repair mechanisms function properly.
However, time was limited. The health of the subjects continued to deteriorate, and it was clear that their lives were in danger. Takashi and his colleagues continued their research day and night, doing their best to find a solution as soon as possible.
Then, one day, while trying a new approach, Takashi and Yuki discovered a gene editing method to suppress abnormalities in cell repair mechanisms. This method had the potential to halt cell aging and prevent abnormal proliferation.
“If this works, we might be able to save the test subjects,” Takashi said excitedly. “Let’s test this new method right away.”
Yuki agreed, and the two immediately began their experiments. After several days of intensive research and experimentation, the new gene editing method was confirmed to be effective in mouse models. It successfully halted cell aging while suppressing abnormal proliferation.
“This is a major breakthrough,” Yuki smiled. “Next, let’s try it on human cells.”
Takashi and Yuki applied the new gene-editing method to the cell samples of the test subjects. The results were astonishing. The subjects’ cells functioned normally and abnormal proliferation was suppressed.
“Now there’s hope,” Takashi couldn’t hide his joy. “Let’s apply this new treatment to our subjects.”
However, it was necessary to report this new discovery to the upper management and obtain permission to proceed with the treatment. Takashi and Yuki once again decided to appeal directly to the upper management.
One day, Takashi and Yuki walked into a conference room where Eternal Life executives were gathered. Takashi took the materials and Yuki set up the projector.
“Ladies and gentlemen, we have made a new discovery,” Takashi began to speak softly but forcefully. “Our new gene editing method can stop cell aging while inhibiting abnormal growth, thereby protecting the health of our subjects.”
The executives were silent for a moment and then began to buzz. One of the executives raised his hand and asked in a calm voice. “Takashi, have you confirmed the safety and efficacy of the new method?”
“Yes, we confirmed this using mouse models and cell samples from test subjects,” Takashi explained, pointing to the material. “We are confident that if we apply this treatment to our subjects, we will be able to restore their health.”
However, the executives remained skeptical. Some of them were concerned about the financial losses that would result from canceling or delaying projects.
“Takashi, we appreciate your research as much as you do, but there are risks involved. Making drastic changes to a project is not easy.” Another executive said.
Takashi replied with strong determination. “As scientists, we should put human life first. People’s lives are more important than profits.”
Yuki strongly agreed. “We need to try new methods. It’s our responsibility as scientists to do everything we can to save our subjects.”
The executives continued to discuss for a while, and then one of the cadres said with a deep sigh. “Okay, Takashi, I’ll give you guys a chance. But if anything goes wrong, you’ll be held responsible.”
Takashi and Yuki nodded at the same time, renewing their determination. “Thank you, I’ll do my best.”
Chapter 4: Life-Saving Challenges
Takashi and Yuki prepared to apply a new treatment to their patients. They were meticulous and carefully monitored the effects and side effects of the treatment. After applying the new gene-editing method to the test subjects, their health began to improve over time.
“With this, we might finally be able to save the test subjects,” Takashi patted his chest in relief.
Yuki was similarly relieved. “When I see the recovery of the subjects, I really feel that the effort has paid off.”
As the treatment progressed, Takashi and his colleagues regularly checked the health of the subjects and collected data. The subjects gradually recovered and no longer suffered from the side effects they had experienced before.
However, not all was well. Some executives were still skeptical, and the pressure on Takashi’s research continued. In addition, media and outside attention also increased, and the actions of Takashi and his colleagues came under close scrutiny.
One day, Takashi returned home and had dinner with Akira. Akira spoke to him anxiously. “Takashi, how’s the situation going lately? Have you made any progress?”
“Slowly but surely, the health conditions of our subjects are improving,” Takashi replied with a smile. “But we can’t relax just yet. We have to constantly check new data and think about the next steps.”
Akira squeezed his hand. “Takashi, what you’re doing is really great. But don’t push yourself too hard. Your health is important too.”
“Thank you, Akira. Your support is the only thing that keeps me going.” Takashi said with gratitude.
That night, while reviewing the data in his study, Takashi noticed a new problem. It turns out that some of the subjects still have minute cellular abnormalities. Takashi hurriedly contacted Yuki and decided to check the data again at his laboratory.
“Yuki, look at this data. Some of the subjects still have cellular abnormalities.” Takashi said as he pointed to the monitor.
Yuki checked the data in detail and replied with a serious expression. “This is unexpected. We may need to make further improvements.”
In order to take new measures, Takashi and his colleagues decided to review the gene editing process again and make further adjustments. They continued to work under pressure from the executives to find the best way to protect their subjects.
A few weeks later, Takashi’s efforts bore fruit once again, and the signs of cell abnormalities gradually faded away. The subjects’ health improved further, and there was a glimmer of hope.
“Now we were finally able to save the subjects,” Takashi said with a look of relief.
Yuki couldn’t hide her joy either. “Takashi, we’ve really done it.”
However, their joy was short-lived, and a new challenge awaited them. Eternal Life’s upper management decided to immediately roll out the new treatment to expedite further commercialization.
However, Takashi and Yuki were deeply concerned about the overly hasty decision of the upper management to commercialize the new treatment. Although the subjects’ health was improving, they did not yet have enough long-term data.
“If we move too fast, new problems may arise,” Takashi said as he and Yuki discussed it together. “We should proceed more cautiously.”
“I agree, Takashi. But I don’t know how to convince the upper management…” Yuki answered anxiously.
The two set up a meeting to try to have a dialogue with upper management. In front of the executives gathered in the conference room, Takashi spoke quietly.
“Ladies and gentlemen, we have confirmed that the new treatment is effective, but we still lack the data to guarantee its long-term safety. Rushing to commercialize is too risky.”
One of the executives replied with a frown. “Takashi, we are aware of the risks involved. However, market demand is growing, and now is an opportune time to expand.”
Takashi took a step forward and appealed forcefully. “If something goes wrong, it will be irreversible. As a scientist, we should act prudently and responsibly.”
Yuki continued. “We still need to do some important tests. We should have at least a few more months of observation.”
But the executives were adamant. In their eyes, profit and market share growth were the top priorities.
“We respect your opinion, but we will not reverse your decision. Please proceed with your preparations.” One of the executives said coldly.
Takashi and Yuki couldn’t hide their disappointment, but they couldn’t give up. Despite the pressure from their superiors, they continued to prioritize the safety of their subjects.
Chapter 5: The Last Hope
Takashi and Yuki remained in the laboratory until late into the night, collecting and analyzing further data. They planned new tests to confirm long-term effects and continued to carefully monitor the health of the subjects.
One day, Takashi was checking the results of a new test with Yuki. The results were astonishing. It turned out that the subjects’ immune systems were strengthened and their cell repair capabilities improved.
“Yuki, look at this, this is a great discovery.” Takashi said excitedly. “Maybe we can use this new data to persuade upper management.”
Yuki was equally excited. “With this data, we can show the dangers of rushing commercialization. Let’s try again.”
The two again asked for another meeting with the executives. The executives saw Takashi and Yuki’s determination and agreed to listen to them again.
“We have new data,” Takashi said emphatically. “This data is important evidence to ensure long-term safety. We need to extend the observation period further.”
Yuki continued. “With this new data, we need to take a closer look at the health of the subjects. Rushing to commercialization would expose us to unidentified risks.”
The executives fell silent again, staring at the data. Some of them were moved by Takashi’s passion and sincerity.
“Okay,” one of the executives said gravely. “We will accept your proposal and extend the observation period. But in the meantime, please show us solid results.”
Takashi and Yuki patted their chests. Their efforts paid off, giving them time to ensure the safety of their subjects.
Chapter 6: The Pursuit of Truth
Takashi and Yuki continued to closely monitor the health of the subjects during the new observation period. They have further improved the AI algorithm to improve the accuracy of the data analysis. The cell repair function of the subjects continued to function smoothly and no cell abnormalities were observed.
“Now we can confidently commercialize this treatment,” Takashi said as he and Yuki stared at the data.
Yuki nodded and smiled. “Our hard work paid off. I’m so glad we were able to save them.”
The executives also agreed to proceed with commercialization based on the new data, and the Eternal Life project was finally launched in earnest. Takashi and Yuki did everything in their power to protect the health of their subjects, and they felt a deep sense of satisfaction that their efforts had borne fruit.
However, Takashi and his colleagues continued to carefully monitor the treatment. Never forgetting their responsibility as scientists, they continued to pursue the truth.
Chapter 7: The Pit of Despair
Thanks to Takashi and Yuki’s efforts, “Project Eternal” appeared to be a success. The new treatment has become widespread, and many people have regained their health and enjoyed a state of near-immortality. Behind the scenes, however, a problem that had been overlooked was quietly unfolding.
One day, after several months had passed, Takashi received an urgent phone call. One of the patients he had treated suddenly began complaining of severe health problems. Takashi rushed to the hospital and witnessed a horrific scene.
The patients had high fevers and unusual swellings and spots all over their bodies. One after another, they lost consciousness in agony, and the medical staff was helpless.
“What the hell is going on here?” asked Takashi to the doctors with a desperate expression.
“I don’t know. These are symptoms I’ve never seen before.” One of the doctors replied with a cloudy face. “If this continues, many lives may be at risk.”
Takashi immediately contacted Yuki, and the two held an emergency meeting. They hastily reviewed the data and did everything in their power to find out the cause of the problem.
“Takashi, look at this,” Yuki said, pointing to the data with a trembling hand. “Unexpected mutations have occurred in some of the treatments. This may be the cause.”
“I never thought… this would happen…” Takashi was speechless. “But now, rather than investigating the cause, we must urgently take measures to minimize the damage.”
Takashi and Yuki formed an emergency response team and took measures to prevent the spread of infection. However, the situation rapidly deteriorated. The condition of the patients worsened, and some began to die.
“It wasn’t supposed to be like this…” Takashi muttered in remorse, “I can’t believe what we’ve done has led to such a tragedy.”
Yuki said with tears in her eyes. “We were trying to save people, but in the end, we have endangered many lives.”
Chapter 8: The Final Battle
Takashi and Yuki once again immersed themselves in research in order to solve the problem of treatment. They did everything in their power to develop new treatments and save the lives of their subjects. However, time was running out, and the infection was spreading rapidly.
“Takashi, this is our last chance,” Yuki said with an exhausted expression. “If this new treatment doesn’t work, there’s nothing left.”
“I know,” Takashi replied determinedly. “We will not give up until the end.”
They rushed to apply new treatments and tried to give hope to their patients. However, the situation worsened beyond expectations. The new treatments did not provide a complete solution, and the patients continued to suffer.
“Takashi, why… why is this happening…” Yuki pleaded with tears in her eyes. “Were we wrong?”
“I don’t know,” Takashi muttered, “We just don’t have any more time.”
Epilogue: The End of Despair
Ultimately, “Project Eternal” came to a tragic end, causing a massive health crisis and claiming many lives. Takashi and Yuki watched as the world collapsed, tormented by grief and deep regret for their actions.
“We stepped into the realm of the gods,” Takashi said, his voice trembling. “The cost was too great.”
Yuki replied in the same way, tearfully. “We wanted to save people, but we ended up taking so many lives.”
The two fought to the end, not giving up hope, but their efforts ended in vain. The tragedy brought about by the pursuit of science will forever be remembered.
Thus, “Project Eternal” came to be remembered as the most catastrophic failure in human history. The story of Takashi and Yuki was passed down to future generations as a symbol of the dangers that arise when the boundaries between science and ethics are crossed.